Alka Chaubey serves as Executive at Bionano Genomics, Inc., where they oversee executive responsibilities. Since joining the company, Alka Chaubey has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 11, 2025 involved selling 51 shares valued at $207.
Alka Chaubey currently holds 662 shares of Bionano Genomics, Inc. (BNGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alka Chaubey has been a net neutral trader of BNGO stock. They have purchased $0 and sold $0 worth of shares.
Alka Chaubey's most recent insider trade was on Sep 11, 2025, when they sold 51 shares at $4.06 per share.
Get notified when new Form 4 filings are submitted
| $0.48 |
| Discretionary |
| Jun 3, 2024 | BNGO | $0 | Award | 16,000 | $N/A | Discretionary |
| Feb 15, 2024 | BNGO | $1.4K | Payment | 1,081 | $1.27 | Discretionary |
| Sep 18, 2023 | BNGO | $0 | Award | 20,000 | $N/A | Discretionary |
| Feb 15, 2023 | BNGO | $0 | Award | 120,000 | $N/A | Discretionary |